The value of exported Norwegian salmon has risen 21 per cent for the first quarter of 2017.

New single-injection salmon vaccine launched in the UK

Published Modified

The vaccine protects against pancreas disease—one of the most costly diseases affecting the salmon industry—as well as furunculosis and infectious pancreatic necrosis (IPN).

Prior to AQUAVAC PD3, two separate injections were administered to protect fish against pancreas disease and other major salmon diseases. Multiple injections not only increase the workload for fish farmers, but can negatively impact fish welfare and growth due to increased handling and extra feed withdrawal periods.

“AQUAVAC PD3 was developed in response to requests from fish farmers for a combination vaccine that protects against major diseases with a single injection,” said Chris Beattie, Ph.D., Head, Global Aquaculture, Merck Animal Health.

“As the global demand for seafood continues to grow, Merck Animal Health is committed to working with our customers to provide innovative solutions such as AQUAVAC PD3, which can help fish farmers save time and increase productivity while protecting against the most common diseases facing the industry.”